Efficacy of Modafinil on Fatigue and Excessive Daytime Sleepiness Associated with Neurological Disorders: A Systematic Review and Meta-Analysis

BACKGROUND: Modafinil is a novel wake-promoting agent approved by the FDA ameliorating excessive daytime sleepiness (EDS) in three disorders: narcolepsy, shift work sleep disorder and obstructive sleep apnea. Existing trials of modafinil for fatigue and EDS associated with neurological disorders pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheng, Ping, Hou, Lijun, Wang, Xiang, Wang, Xiaowen, Huang, Chengguang, Yu, Mingkun, Han, Xi, Dong, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849275/
https://www.ncbi.nlm.nih.gov/pubmed/24312590
http://dx.doi.org/10.1371/journal.pone.0081802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849275/
https://www.ncbi.nlm.nih.gov/pubmed/24312590
http://dx.doi.org/10.1371/journal.pone.0081802

Ejemplares similares